8 July 2024 in Annals of Clinical and Experimental Neurology
Introduction. Astrocytes are involved in mediator metabolism, neuroplasticity, energy support of neurons and neuroinflammation, and this determines their pathogenetic role in epilepsy. Aim. This study aimed at evaluating region-specific changes in the distribution of functional astroglial proteins in reactive astrocytes in a kainate-induced model of mesial temporal lobe epilepsy. Materials and methods. The localization and expression of functional astroglial proteins (i.e. aquaporin-4, connexin-43, EAAT1/2, and glutamine synthetase) in the hippocampus CA3 region, dentate gyrus, and stratum lucidum layer were evaluated by immunofluorescence 28 days after intra-hippocampal administration of kainic acid to animals. Results. Changes were heterogeneous in different hyppocampus subregions. Astrocytes of the stratum lucidum associated with mossy fibers showed the highest vulnerability and decreased content and/or disturbed localization of the channels and transporters that form membrane complexes in the processes. Disturbances in homeostatic functions of astrocytes aggravated the adverse processes both on the side where the toxin was injected and in the contralateral hippocampus.
6 December 2024 in Annals of Clinical and Experimental Neurology
Introduction. With the number of patients with Parkinson's disease steadily growing, the need for novel treatment approaches is increasing. Combining transplantation of neuronal progenitors derived from induced pluripotent stem cells and transcranial direct current stimulation (tDCS) is among the promising methods. Aim: to examine the effect of tDCS on the cell graft condition and motor symptoms of Parkinson's syndrome in rats. Materials and methods. Parkinson's syndrome was modeled in Wistar rats by the unilateral intranigral injection of 6-hydroxydopamine (6-OHDA; 12 μg in 3 μL) The model rats underwent neurotransplantation (3 × 105 cells in 10 μL) into the caudate nuclei on the affected side. The animals underwent tDCS for 14 days. Behavioral changes were analyzed by open field and beam-walking tests. Development and morphological characteristics of the graft were assessed by the morphochemical study. Results. Neurotransplantation had no significant effect on the behavior of rats with parkinsonism; however, combined with tDCS, it increased motor activity during the open field tests compared with the group of model rats (р = 0.0014) and mitigated their anxiety-related behaviors (р = 0.048) in tests at 3 weeks after the transplantation. These effects were not observed in tests at 3 months. The morphochemical study revealed larger graft sizes in the animals that underwent tDCS compared with the controls and cell shift to the marginal zone of the graft. Stimulation was also shown to induce division of a part of cells at early stages of differentiation and promote active synaptogenesis. Conclusion. Combining neurotransplantation and tDCS in the 6-OHDA-induced model of parkinsonism demonstrated its potential to manage both motor and non-motor symptoms. Optimizing protocols of transplantation and tDCS and evaluating their long-term efficacy and safety are required to successfully implement this method into clinical practice.
20 December 2025 in Neurology, Neuropsychiatry, Psychosomatics
Currently, glucagon-like peptide-1 receptor agonists (GLP-1RAs) are considered promising drugs for the treatment of Alzheimer's disease (AD) and other neurodegenerative diseases due to their complex mechanism of action, which includes (in addition to general somatic effects) an impact on neuroplasticity. This necessitates a detailed study of drugs in this group using appropriate informative experimental models. Objective: to characterise the effect of semaglutide, one of the main representatives of the GLP-1RAs class, on the development of neurodegenerative processes in the hippocampus and cognitive impairments in animals with a streptozocin (STZ) model of AD. Material and methods . Streptozocin at a dose of 3 mg/kg was administered into the lateral ventricles of Wistar rats, and semaglutide at a dose of 0.1 mg/kg was administered intraperitoneally (every other day for 5 weeks). The behaviour of the animals was assessed in the ‘Novel Object Recognition’ and ‘T-Maze’ tests. Nine weeks after discontinuation of the drug, immunomorphological methods were used to determine the effect of semaglutide on neurodegenerative processes in the CA3 field of the hippocampus. Results. Streptozocin caused impaired recognition of a new object and increased the latency period for entering the closed arm of the T-maze, as well as leading to tau protein accumulation and mitochondrial and synaptic abnormalities in the CA3 field of the hippocampus. Semaglutide significantly attenuated streptozocin-induced memory impairment and depression-like behaviour and improved morphological indicators of synaptic integrity (based on the detection of synaptophysin and PSD95 proteins) neuronal energy metabolism (as determined by the detection of glycolysis and oxidative phosphorylation enzymes), and reduced tau protein phosphorylation. Conclusion . In a model of sporadic AD, semaglutide has been shown to attenuate cognitive impairment in laboratory animals and reduce the severity of morphological abnormalities in the CA3 region of the hippocampus, with the neuroprotective effect of the drug persisting after discontinuation of therapy.
24 November 2025 in Research Results in Pharmacology
Introduction: Reactive changes in glial cells, as well as their dysfunction, particularly cerebrospinal fluid dynamics disturbances, are associated with multiple neurodegenerative diseases and Alzheimer’s disease (AD). Intraventricular administration of streptozotocin (STZ) is considered a model of sporadic AD, though data on hypothalamic glial cell changes, ependymal glia, and tanycytes in this model remain limited. Of particular interest is the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to address STZ-induced changes following intraventricular administration. Material and Methods: Using immunomorphological methods, this study assessed changes in staining density and distribution of glial proteins (GFAP, aquaporine-4, connexin 43, vimentin) and neuronal alterations in hypothalamic structures following intraventricular STZ administration (3 mg/kg) and course treatment with intraperitoneal semaglutide (0.1 mg/kg, 16 injections). Results: STZ caused neuronal damage in the ventromedial hypothalamic nucleus, disrupted the ependymal lining and tanycytes of the third ventricle, induced reactive astrogliosis, and altered the distribution of aquaporin-4 and connexin-43. Semaglutide administration reduced astroglial activation, normalized aquaporin and connexin distribution, decreased neuronal death, and suppressed caspase-3 activation in the ventromedial hypothalamic nucleus. Conclusion: Intraventricular single-dose STZ administration causes long-term impairment of glial functions related to cerebrospinal fluid exchange. The course treatment GLP-1R agonist semaglutide (started 5 days after streptozocin administration, 16 injections every other day) demonstrated normalizing effects on both glial and neuronal parameters in the STZ-induced AD model.
25 December 2025 in Annals of Clinical and Experimental Neurology
Introduction. Mdivi-1, an inhibitor of mitochondrial fission, has neuroprotective potential and can modulate pathological neuroplasticity, which is of interest for developing pharmacological therapies for mesial temporal lobe epilepsy. The aim of this study is to summarize the results of a series of experiments with mdivi-1 on a model of kainate-induced hippocampal damage and evaluate the prospects of modulating mitochondrial dynamics to suppress neurodegeneration and aberrant plasticity. Materials and methods. Wistar rats received kainic acid injections into the hippocampus and mdivi-1 into the lateral cerebral ventricles. Immunomorphological assessment included evaluation of proliferation and differentiation (using BrdU), maturation and damage of granule layer hippocampal neurons (assessing numbers of NeuN- and DCX-positive cells), glial reaction, and changes in mitochondrial dynamics (dynamin-related protein and mitofusin 2). The animals’ ability for novel object recognition and response to photostimulation were studied. Results. Mdivi-1 showed no neuroprotective effect on mature hippocampal neurons following kainic acid administration, but reduced microglial activation in the dentate gyrus without affecting reactive astrogliosis. Mdivi-1 also suppressed maturation and differentiation of granule layer hippocampal neurons in both control animals and the kainate model, but no positive behavioral effects of mdivi-1 exposure were observed. Conclusion. The data indicate the potential of modulating aberrant neurogenesis through inhibition of mitochondrial division; however, the practical prospects of using mdivi-1 for addressing abnormal processes in the hippocampus are limited by the multiplicity of mdivi-1 effects on different hippocampal cell populations and the complexity of their control.
30 June 2026 in Annals of Clinical and Experimental Neurology
Introduction. Spinocerebellar ataxias lead to severe disability and impose a significant burden on healthcare systems. Experimental models are indispensable for reproducing the behavioral manifestations of ataxia and investigating novel therapeutic approaches; however, they do not fully replicate the entire spectrum of disease symptoms. Combined models are the most promising, as they more accurately reflect the complex pathogenetic mechanisms of neurodegeneration. Study aim: To assess the representativeness of the spinocerebellar ataxia phenotype model following combined exposure to lipopolysaccharide (LPS) and 3-acetylpyridine (3-AP) using behavioral tests. Materials and methods. The study was conducted on male Wistar rats (n = 30), randomly assigned to 4 groups. Animals in the Control+LPS and LPS+3-AP groups received LPS (40 μg in 10 μL) via bilateral intracerebroventricular (ICV) injection; rats in the Control and PS+3-AP groups received an equivalent volume of physiological saline. Three days later, animals in the PS+3-AP and LPS+3-AP groups received intraperitoneal injections of 3-AP (40 mg/kg); the Control and LPS+PS groups received physiological saline. The development of motor impairments was assessed using behavioral tests. Immunohistochemical methods were used to identify Purkinje cell (aldolase C) and microglial (IBA1) markers on cerebellar sections. Results. Body weight significantly decreased following combined exposure (p 0.01) and 3-AP alone (p 0.05), but not following LPS alone (p 0.05). Motor function impairments were significant in the LPS+3-AP and Control+3-AP groups (p 0.05). In the Control+LPS group, only isolated parameters showed significant changes compared to controls. Qualitative morphological analysis revealed more pronounced Purkinje cell dystrophy and microglial activation following combined exposure. Conclusion. Combined exposure to LPS and 3-AP reproduces a more pronounced ataxic phenotype, indicating a possible sensitizing effect of neuroinflammation and supporting the utility of this model for further investigation of this process.